The role of epigenetics in malignant pleural mesothelioma

Fabian Vandermeers1, Sathya Neelature Sriramareddy1, Chrisostome Costa1

  • 1Molecular and Cellular Epigenetics (GIGA-Cancer) and Molecular Biology (GxABT), University of Liège (ULg), Liège, Belgium.

Insights

Malignant pleural mesothelioma (MPM) is a fatal cancer linked to asbestos. Epigenetic errors cause chemotherapy resistance, but new epigenetic therapies targeting these changes show promise for treating MPM.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Malignant pleural mesothelioma (MPM) is a fatal cancer primarily caused by asbestos exposure.
  • Chemotherapy resistance in MPM is increasingly linked to epigenetic alterations affecting gene expression.
  • Epigenetic modifications, including histone acetylation and DNA methylation, are key regulatory mechanisms in cancer.

Purpose of the Study:

  • To review recent advancements in understanding epigenetics in mesothelioma.
  • To explore novel epigenetic therapy strategies for MPM treatment.
  • To highlight the potential of targeting epigenetic errors for improved MPM outcomes.

Main Methods:

  • Literature review of recent findings on epigenetics in mesothelioma.
  • Analysis of current and emerging epigenetic therapeutic compounds.
  • Synthesis of evidence linking epigenetic modifications to MPM pathogenesis and treatment response.

Main Results:

  • Epigenetic dysregulation is a significant factor in MPM development and chemoresistance.
  • Compounds modulating histone acetylation and DNA methylation are emerging as promising therapeutic agents.
  • Targeting epigenetic errors offers a novel approach to overcome treatment unresponsiveness in MPM.

Conclusions:

  • Epigenetic therapies represent a promising frontier for treating malignant pleural mesothelioma.
  • Further research into epigenetic mechanisms and targeted interventions is crucial for improving patient survival.
  • Modulating epigenetic modifications holds potential to overcome chemotherapy resistance in MPM.

Related Concept Videos

Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Pleural Disorders: Types and Brief Description01:30

Pleural Disorders: Types and Brief Description

The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...